DATE: 4 May 2022 (Wednesday)
TIME: 15:00 - 16:00 CEST

Vaccines, new medicines, diagnostics, in-home care, and more detailed and sophisticated clinical trials that bring drugs to those who need them faster and more efficiently are all being helped by tandem developments in technology. How are digital innovators tackling the diseases and conditions that increase in prevalence with age, including vision impairment, cardiovascular disease, osteoporosis and fragility fractures, cancer, dementia and other neurological disorders, and communicable diseases that place older adults at high risk, such as influenza, shingles, pneumococcal pneumonia, and COVID-19? How is achieving the goals of the Decade of Healthy Ageing uniquely connected to technology innovation?

Panellists
 

• Ms Amal Abou Rafeh  (Moderator) - Chief, Programme on Ageing Section, Social Inclusion and Participation Branch, Division for Inclusive Social Development, UN DESA
• Dr Jian Yang - Associate VP, Digital Health, Eli Lilly and Co.
• Ms Diane Thomson - Senior Director, Vaccines Public Affairs, Global Policy & Public Affiars, Pfizer
• Ms Jennifer Lavelle - Head of Global Business Marketing, Ambulatory, Monitoring & Diagnostics, Philips
• Dr Mike Devoy - Chief Medical Officer and Executive VP Medical Affairs & Pharmacovigilance, Pharmaceutical Division, Bayer
• Dr Michelle Johnson - Associate Professor of Physical Medicine and Rehabilitation, University of Pennsylvania Medical School